Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Strides Pharma Science Ltd
NSE:STAR
Strides Pharma Science Ltd
NSE:STAR
Price:
1 070
INR
-2.51%
Market Closed
Market Cap:
₹98.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Strides Pharma Science Ltd
NSE:STAR
|
IN |
|
B
|
Bank of Nova Scotia
F:BKN
|
CA |
|
Mastermyne Group Ltd
ASX:MYE
|
AU |
Wall St Price Targets
STAR Price Forecast
Based on 3 analysts
Based on 3 analysts
+34% Upside
from
₹1 070
today
Strides Pharma Science Ltd (STAR)’s 12-month stock price forecast through October 2027 has a consensus target of ₹1 438.2, implying 34% upside. The forecast is based on price targets from 3 Wall Street analysts.
STAR Analyst Rating
No ratings yet
No ratings yet
Strides Pharma Science Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is STAR's stock price target?
Price Target
1 438.2
INR
1 438.2
INR
According to Wall Street analysts, the average 1-year price target for STAR is 1 438.2 INR with a low forecast of 1 424.1 INR and a high forecast of 1 480.5 INR.
What is the Revenue forecast for Strides Pharma Science Ltd?
Projected CAGR
22%
22%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 2 years is 22%.
What is the Gross Profit forecast for Strides Pharma Science Ltd?
Projected CAGR
27%
27%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 2 years is 27%.
What is the Operating Income forecast for Strides Pharma Science Ltd?
Projected CAGR
68%
68%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is 68%.
What is the Pre-Tax Income forecast for Strides Pharma Science Ltd?
Projected CAGR
32%
32%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 2 years is 32%.
What is the Net Income forecast for Strides Pharma Science Ltd?
Projected CAGR
30%
30%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 2 years is 30%.